Cargando…

Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays

BACKGROUND: Low molecular weight heparins (LMWH’s) are used to prevent and treat thrombosis. Tests for monitoring LMWH’s include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH’s varying affinities fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Owain, Lybeck, Emanuel, Strandberg, Karin, Tynngård, Nahreen, Schött, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308107/ https://www.ncbi.nlm.nih.gov/pubmed/25625201 http://dx.doi.org/10.1371/journal.pone.0116835

Ejemplares similares

Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
por: Byun, Jung-Hyun, et al.
Publicado: (2016)

Thromboelastometry versus free-oscillation rheometry and enoxaparin versus tinzaparin: an in-vitro study comparing two viscoelastic haemostatic tests’ dose-responses to two low molecular weight heparins at the time of withdrawing epidural catheters from ten patients after major surgery
por: Thomas, Owain, et al.
Publicado: (2015)

Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
por: Lardinois, Benjamin, et al.
Publicado: (2022)

Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?
por: Anton, Florin Ioan, et al.
Publicado: (2020)

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
por: Shin, Dong-Yeop, et al.
Publicado: (2015)

The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation
por: Shimomura, Daiki, et al.
Publicado: (2020)

The biphasic aPTT waveform to diagnose sepsis in patients with systemic inflammatory response syndrome
por: Hagg, D, et al.
Publicado: (2007)

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
por: Nguyen, Tung Phi, et al.
Publicado: (2021)

Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
por: Smit, Bob, et al.
Publicado: (2023)

Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study
por: Kander, Thomas, et al.
Publicado: (2016)

Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections
por: Tan, Chuen Wen, et al.
Publicado: (2020)

Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019)

Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
por: Bronić, Ana, et al.
Publicado: (2021)

Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates
por: Winstedt, Dag, et al.
Publicado: (2013)

An Unusual Etiology for Elevation of Activated Partial Thromboplastin Time (aPTT) in SLE: Acquired Hemophilia and Lupus Anticoagulant
por: Seethala, Srikanth, et al.
Publicado: (2013)

Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis
por: Trudzinski, Franziska C., et al.
Publicado: (2016)

Assays of different aspects of haemostasis – what do they measure?
por: Tynngård, Nahreen, et al.
Publicado: (2015)

Monitoring of treatment with low molecular weight heparins using viscoelastic devices
por: Schött, U, et al.
Publicado: (2014)

Pre- to postoperative coagulation profile of 307 patients undergoing oesophageal resection with epidural blockade over a 10-year period in a single hospital: implications for the risk of spinal haematoma
por: Thomas, Owain, et al.
Publicado: (2017)

Patient with lupus anticoagulant caused aPTT prolongation corrected with prednisolone treatment and later anticoagulation treatment due to chronic atrial fibrillation
por: Frydrysiak, Marlena, et al.
Publicado: (2023)

Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis
por: Rajsic, Sasa, et al.
Publicado: (2023)

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Serum albumin at resection predicts in-hospital death, while serum lactate and aPTT on the first postoperative day anticipate anastomotic leakage after Ivor-Lewis-esophagectomy
por: Scheufele, Florian, et al.
Publicado: (2022)

The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa
por: Figueiredo, Ana C., et al.
Publicado: (2013)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Investigation of active matrix- metaloproteinase-8 (aMMP-8) as a reference parameter for path control in antimicrobial photothermal therapy (aPTT) using a split-mouth design
por: Deumer, J., et al.
Publicado: (2019)

DIC Score: Statistical Relationship with PT, APTT, and Simplified Scoring Systems with Combinations of PT and APTT
por: Chandrashekar, Vani
Publicado: (2012)

Procoagulant activity of human tumours: existence of Xa and thrombin-like activities.
por: Sarode, R., et al.
Publicado: (1990)

Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes
por: Hornung, Paul, et al.
Publicado: (2020)

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
por: Xu, Lengnan, et al.
Publicado: (2023)

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy
por: McLaughlin, Kevin, et al.
Publicado: (2019)

Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples—an experimental study
por: Strandberg, Gunnar, et al.
Publicado: (2016)

Prominent Crystallization Promotion Effect of Montmorillonite on PTT/PC Blends with PTT as the Continuous Phase
por: Xue, Meiling, et al.
Publicado: (2020)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

Factor Xa Generation by Computational Modeling: An Additional Discriminator to Thrombin Generation Evaluation
por: Brummel-Ziedins, Kathleen E., et al.
Publicado: (2012)

Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex
por: Yegneswaran, Subramanian, et al.
Publicado: (2015)

Coagulative safety of epidural catheters after major upper gastrointestinal surgery: advanced and routine coagulation analysis in 38 patients
por: Thomas, Owain, et al.
Publicado: (2016)

Determination of APTT factor sensitivity – the misguiding guideline
por: Lawrie, A S, et al.
Publicado: (2013)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4c3d43asiaomaov3meofmqgt2d